Coulrophobia: An investigation of clinical features

por Planting, Talia, Koopowitz, Sheri-Michelle, Stein, Dan J.
Publicado 2022

Improving word reading speed: individual differences interact with a training focus on successes or failures

por Steenbeek-Planting, Esther G., van Bon, Wim H. J., Schreuder, Robert
Publicado 2011

Reactive astrocytes in multiple sclerosis impair neuronal outgrowth through TRPM7‐mediated chondroitin sulfate proteoglycan production

por Kamermans, Alwin, Planting, Kirsten E., Jalink, Kees, van Horssen, Jack, de Vries, Helga E.
Publicado 2018

Phase I/II study of a short course of weekly cisplatin in patients with advanced solid tumours.

por Planting, A. S., van der Burg, M. E., de Boer-Dennert, M., Stoter, G., Verweij, J.
Publicado 1993

Can Use of Digital Technologies by People with Dementia Improve Self-Management and Social Participation? A Systematic Review of Effect Studies

por Neal, David, van den Berg, Floor, Planting, Caroline, Ettema, Teake, Dijkstra, Karin, Finnema, Evelyn, Dröes, Rose-Marie
Publicado 2021

Treatment of patients with metastatic pancreatic and gastrointestinal tumours with the somatostatin analogue Sandostatin: a phase II study including endocrine effects.

por Klijn, J. G., Hoff, A. M., Planting, A. S., Verweij, J., Kok, T., Lamberts, S. W., Portengen, H., Foekens, J. A.
Publicado 1990

A phase II study of epidoxorubicin in colorectal cancer and the use of cyclosporin-A in an attempt to reverse multidrug resistance.

por Verweij, J., Herweijer, H., Oosterom, R., van der Burg, M. E., Planting, A. S., Seynaeve, C., Stoter, G., Nooter, K.
Publicado 1991

Differential lexical predictors of reading comprehension in fourth graders

por Swart, Nicole M., Muijselaar, Marloes M. L., Steenbeek-Planting, Esther G., Droop, Mienke, de Jong, Peter F., Verhoeven, L.
Publicado 2016

PCDDs, PCDFs, and PCBs in human blood in relation to consumption of crabs from a contaminated Fjord area in Norway.

por Johansen, H R, Alexander, J, Rossland, O J, Planting, S, Løvik, M, Gaarder, P I, Gdynia, W, Bjerve, K S, Becher, G
Publicado 1996

Phase II study of a short course of weekly high-dose cisplatin combined with long-term oral etoposide in metastatic colorectal cancer.

por Planting, A. S., van der Burg, M. E., van den Bent, M. J., de Boer-Dennert, M., Stoter, G., Verweij, J.
Publicado 1996

A phase I and pharmacokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumours

por Pronk, L C, Vasey, P, Sparreboom, A, Reigner, B, Planting, A S Th, Gordon, R J, Osterwalder, B, Verweij, J, Twelves, C
Publicado 2000

The effects of psychosocial interventions using generic photos on social interaction, mood and quality of life of persons with dementia: a systematic review

por Tan, Josephine Rose Orejana, Boersma, Petra, Ettema, Teake P., Planting, Caroline H. M., Clark, Soraya, Gobbens, Robbert J. J., Dröes, Rose-Marie
Publicado 2023

Current sample handling methods for measurement of platinum-DNA adducts in leucocytes in man lead to discrepant results in DNA adduct levels and DNA repair.

por Ma, J., Verweij, J., Planting, A. S., de Boer-Dennert, M., van Ingen, H. E., van der Burg, M. E., Stoter, G., Schellens, J. H.
Publicado 1995

Phase I study on docetaxel and ifosfamide in patients with advanced solid tumours.

por Pronk, L. C., Schrijvers, D., Schellens, J. H., de Bruijn, E. A., Planting, A. S., Locci-Tonelli, D., Groult, V., Verweij, J., van Oosterom, A. T.
Publicado 1998

Relationship between the exposure to cisplatin, DNA-adduct formation in leucocytes and tumour response in patients with solid tumours.

por Schellens, J. H., Ma, J., Planting, A. S., van der Burg, M. E., van Meerten, E., de Boer-Dennert, M., Schmitz, P. I., Stoter, G., Verweij, J.
Publicado 1996

The bioavailability of oral GI147211 (GG211), a new topoisomerase I inhibitor.

por Gerrits, C. J., Schellens, J. H., Creemers, G. J., Wissel, P., Planting, A. S., Pritchard, J. F., DePee, S., de Boer-Dennert, M., Harteveld, M., Verweij, J.
Publicado 1997

Phase I and pharmacological study of the new topoisomerase I inhibitor GI147211, using a daily x 5 intravenous administration.

por Gerrits, C. J., Creemers, G. J., Schellens, J. H., Wissel, P., Planting, A. S., Kunka, R., Selinger, K., de Boer-Dennert, M., Marijnen, Y., Harteveld, M., Verweij, J.
Publicado 1996

A phase I dose escalation study of BIBW 2992, an irreversible dual inhibitor of epidermal growth factor receptor 1 (EGFR) and 2 (HER2) tyrosine kinase in a 2-week on, 2-week off sc...

por Eskens, F A L M, Mom, C H, Planting, A S T, Gietema, J A, Amelsberg, A, Huisman, H, van Doorn, L, Burger, H, Stopfer, P, Verweij, J, de Vries, E G E
Publicado 2008

A phase I/II study of multicyclic dose-intensive chemotherapy supported with G-CSF, or G-CSF and haematopoietic progenitor cells in whole blood, in two consecutive cohorts of patie...

por de Wit, R., Kruit, W. H., Lamers, C. H., van 't Veer, M. B., Luyten, A. A., van Beurden, V., Harteveld, M., Planting, A. S., Schmitz, P. I., Stoter, G., Bolhuis, R. L., Verweij, J.
Publicado 1998

Weekly high-dose cisplatin is a feasible treatment option: analysis on prognostic factors for toxicity in 400 patients

por de Jongh, F E, van Veen, R N, Veltman, S J, de Wit, R, van der Burg, M E L, van den Bent, M J, Planting, ASTh, Graveland, W J, Stoter, G, Verweij, J
Publicado 2003